[Federal Register Volume 78, Number 123 (Wednesday, June 26, 2013)]
[Notices]
[Page 38302]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-15244]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
Veterans' Advisory Board on Dose Reconstruction; Notice of
Meeting
AGENCY: Defense Threat Reduction Agency, DoD.
ACTION: Advisory Board meeting notice.
-----------------------------------------------------------------------
SUMMARY: Under the provisions of the Federal Advisory Committee Act of
1972 (5 U.S.C., Appendix, as amended) and the Government in the
Sunshine Act of 1976 (5 U.S.C. 552b, as amended), the Defense Threat
Reduction Agency (DTRA) and the Department of Veterans Affairs (VA)
announce the following advisory board meeting of the Veterans' Advisory
Board on Dose Reconstruction (VBDR).
DATES: Tuesday, July 23, 2013, from 7:30 a.m. to 6:30 p.m. The public
is invited to attend. A public comment session is scheduled from 4:00
p.m. to 5:00 p.m.
ADDRESSES: Hilton Arlington Hotel, 950 North Stafford Street,
Arlington, VA 22203.
FOR FURTHER INFORMATION CONTACT: The Veterans' Advisory Board on Dose
Reconstruction may be contacted toll-free at 1-866-657-VBDR (8237).
Additional information may be found at http://www.vbdr.org.
SUPPLEMENTARY INFORMATION:
Purpose of Meeting: To obtain, review and evaluate information
related to the Board's mission to provide guidance and oversight of the
dose reconstruction and claims compensation programs for veterans of
U.S.-sponsored atmospheric nuclear weapons tests from 1945-1962;
veterans of the 1945-1946 occupation of Hiroshima and Nagasaki, Japan;
and veterans who were prisoners of war in those regions at the
conclusion of World War II. In addition, the advisory board will assist
the VA and DTRA in communicating with the veterans.
Meeting Agenda: The meeting will open with an introduction of the
Board. After introductions, the following briefings will be presented:
``Review of Atomic Veterans Epidemiology Study''; ``Update on the NTPR
Dose Reconstruction Program''; ``Update on the VA Radiation Claims
Compensation program for Veterans''; ``Overview of the VA's Office of
Post Deployment Health''; ``Presentation of the VA/DTRA/VBDR Atomic
Veterans Communications Plans''; ``McMurdo Sound Radiation Dose
Assessment''; ``Utility of NIOSH-IREP Probability of Causation Software
for Evaluating Probability of Disease Causation for McMurdo Station
Veterans''; ``VBDR SC1 and SC2 Comments on McMurdo Station Dose
Reconstruction and NIOSH-IREP's Utility for Evaluating Probability of
Disease Causation for McMurdo Station Veterans''. The Board members
will then have a discussion period to address any issues brought up
during the presentations. The four subcommittees will also report on
their activities from the past year. The subcommittees are the
``Subcommittee on DTRA Dose Reconstruction Procedures'', the
``Subcommittee on VA Claims Adjudication Procedures'', the
``Subcommittee on Quality Management and VA Process Integration with
DTRA Nuclear Test Personnel Review Program'', and the ``Subcommittee on
Communication and Outreach.''
Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended and 41
CFR 102-3.140 through 102-3.165, and the availability of space, this
meeting is open to the public. Seating is limited by the size of the
meeting room. All persons must sign in legibly at the registration
desk.
Written Statements: Pursuant to 41 CFR 102-3.105(j) and 102-
3.140(c), interested persons may submit a written statement for
consideration by the Veterans' Advisory Board on Dose Reconstruction.
Written statements should be no longer than two type-written pages and
must address: the issue, discussion, and recommended course of action.
Supporting documentation may also be included as needed to establish
the appropriate historical context and to provide any necessary
background information. Individuals submitting a written statement may
submit their statement to the Board at 801 N. Quincy Street, Suite 700,
Arlington, VA 22203, at any time. However, if a written statement is
not received at least 10 calendar days prior to the meeting, which is
the subject of this notice, then it may not be provided to or
considered by the Veterans' Advisory Board on Dose Reconstruction until
its next open meeting.
The Chairperson will review all timely submissions with the
Designated Federal Officer, and ensure they are provided to members of
the Veterans' Advisory Board on Dose Reconstruction before the meeting
that is the subject of this notice. After reviewing the written
comments, the Chairperson and the Designated Federal Officer may choose
to invite the submitter of the comments to orally present their issue
during an open portion of this meeting or at a future meeting.
Public Comments: The July 23, 2013 meeting is open to the public. A
one-hour session, scheduled from 4:00 p.m. to 5:00 p.m., will be
reserved for public comments on issues related to the tasks of the
Veterans' Advisory Board on Dose Reconstruction. Speaking time will be
assigned on a first-come, first-served basis. The amount of time per
speaker will be determined by the number of requests received, but is
nominally five minutes each. All persons who wish to speak at the
meeting must sign in legibly at the registration desk. Speakers who
wish to expand on their oral statements are invited to submit a written
statement to the Veterans' Advisory Board on Dose Reconstruction at 801
N. Quincy Street, Suite 700, Arlington, VA 22203.
Committee's Designated Federal Officer or Point of Contact: Mr.
Stephen Polchek, DoD, Defense Threat Reduction Agency/J/2/5/8R-ACP,
8725 John J. Kingman Road, MS 6201, Fort Belvoir, VA 22060-6201. Email:
[email protected], Phone: 703-767-8891.
Dated: June 21, 2013.
Aaron Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2013-15244 Filed 6-25-13; 8:45 am]
BILLING CODE 5001-06-P